Skip To Main Content
Carmen Lam on Muck Rack

Carmen Lam

As seen in: MDPI, Lexology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Carmen Lam’s profile

Articles by Carmen Lam

Normalising high-stakes innovation: insights from Hong Kong’s first intraoperative magnetic resonance imaging service

|
By Carmen Lam
| hkmj.org
Hong Kong Med J 2026;32:Epub 21 Jul 2026 EDITORIAL Normalising high-stakes innovation: insights from Hong Kong’s first intraoperative magnetic resonance imaging service Carmen KM Lam, MB, BS, MMed1; Philip YS Lee, MB, BS2; WN Ho, MB, ChB3; ST Wong, MB, BS3; Benny CP Cheng, BSc, MB, BS1; Ivan YC Wong, MB, BS2 1 Department of Anaesthesia and Operating Theatre Services, Tuen Mun Hospital, Hong Kong SAR, China 2 Department of Diagnostic Radiology, Tuen Mun Hospital, Hong Kong SAR, China 3...
Open in Who Shared Issue with article?

Digitalisation and IT Strategy in the Hospitality Industry

|
By Martin Wynn, Carmen Lam
| MDPI
Open AccessArticle by 1,* and 2 1 School of Business, Computing and Social Sciences, University of Gloucestershire, Cheltenham GL502RH, UK 2 Crikx & Co. Ltd., Discovery Bay, Hong Kong * Author to whom correspondence should be addressed. Systems 2023, 11(10), 501; https://doi.org/10.3390/systems11100501 (registering DOI) Received: 30 August 2023 / Revised: 25 September 2023 / Accepted: 29 September 2023 / Published: 1 October 2023 1.
Open in Who Shared Issue with article?

Congress Enacts Legislation Requiring Guidance on Clinical Research Diversity and Modernization

|
By David Peloquin, Mark Barnes Verified, Carmen Lam
| Lexology Verified
On December 29, 2022, President Biden signed into law the Consolidated Appropriations Act, 2023 (H.R. 2617), an omnibus appropriations bill to fund the U.S. government through fiscal year 2023. Included in the omnibus bill is the Food and Drug Omnibus Reform Act of 2022 (“FDORA”), which includes several provisions intended to promote diversity in clinical trial enrollment, encourage the growth of decentralized clinical trials, and streamline clinical trials.
Open in Who Shared Issue with article?
Show More